Besides the deleterious action on MSC, obesity-associated low-grade chronic inflammation, through the increase in proinflammatory mediators and the activation of immune-mediated mechanisms, may lead to a progressive decrease in muscle mass paralleled by a shift in tissue composition towards fat deposition and accumulation in muscle due to increased insulin resistance [85]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.